Related by context. Frequent words. (Click for all words.) 74 L Annamycin 72 Amrubicin 72 liposomal formulation 71 phase IIb clinical 71 Voreloxin 71 relapsed multiple myeloma 70 ATL# [001] 70 Mipomersen 70 pertuzumab 70 elotuzumab 70 Atiprimod 70 Epratuzumab 70 orally bioavailable 70 anticancer compound 70 Panzem R 70 R sorafenib tablets 69 Irinotecan 69 forodesine 69 PEG SN# 69 metastatic hormone refractory 69 Phase Ib clinical 69 multi kinase inhibitor 69 Dasatinib 69 Guanilib 69 Onalta 69 IMC A# 69 metastatic castration resistant 69 Acute Myeloid Leukemia AML 69 Lu AA# 68 relapsing multiple sclerosis 68 KNS # 68 Sym# 68 advanced carcinoid 68 Carfilzomib 68 Zolinza 68 ganetespib 68 Herceptin trastuzumab 68 HER2 positive metastatic breast 68 HGS ETR1 68 BAY #-# 68 leukemia CLL 68 Azedra 68 registrational trial 68 relapsed refractory multiple myeloma 68 MEK inhibitor 67 KRN# 67 BrachySil 67 EOquin 67 mTOR inhibitor 67 multiple myeloma MM 67 PXD# 67 SAR# [004] 67 eniluracil 67 myeloproliferative disorders 67 Metastatic Melanoma 67 BZL# 67 Bicifadine 67 OncoVEX GM CSF 67 non alcoholic steatohepatitis 67 OXi# 67 tyrosine kinase inhibitor 67 phase IIb 66 Icatibant 66 anti mitotic 66 Laquinimod 66 angiogenesis inhibitor 66 Tesetaxel 66 BNC# 66 Pivotal Phase III 66 Clavis Pharma 66 Pirfenidone 66 metastatic renal cell carcinoma 66 CCX# 66 Phase IIa clinical 66 humanized anti 66 anticancer agent 66 Drug Candidate 66 CYC# 66 Vandetanib 66 dirucotide 66 romidepsin 66 refractory multiple myeloma 66 Phase Ib 66 Nexavar ® 66 Bortezomib 66 docetaxel chemotherapy 66 Traficet EN 65 Perifosine 65 deforolimus 65 CR# vcMMAE 65 MOZOBIL 65 Phase 2b clinical trials 65 Desmoteplase 65 phase IIa 65 MGCD# [001] 65 otelixizumab 65 antisense drug 65 Eltrombopag 65 atacicept 65 pseudobulbar affect PBA 65 Pivotal Phase